دورية أكاديمية
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study.
| العنوان: | Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study. |
|---|---|
| المؤلفون: | Kawabata, Ryohei, Chin, Keisho, Takahari, Daisuke, Hosaka, Hisashi, Muto, Osamu, Shindo, Yoshiaki, Nagata, Naoki, Yabusaki, Hiroshi, Imamura, Hiroshi, Endo, Shunji, Kashiwada, Tomomi, Nakamura, Masato, Hihara, Jun, Kobayashi, Michiya, Sagawa, Tamotsu, Saito, Soh, Sato, Atsushi, Yamada, Takeshi, Okano, Naohiro, Shimada, Ken, Matsushima, Masashi, Kataoka, Masato, Matsumoto, Shigemi, Goto, Masahiro, Kotaka, Masahito, Shiraishi, Takeshi, Yamai, Hiromichi, Nagashima, Fumio, Ishizuka, Naoki, Yamaguchi, Kensei |
| المصدر: | Gastric Cancer ; ISSN:1436-3305 ; Volume:26 ; Issue:6 |
| بيانات النشر: | Springer |
| سنة النشر: | 2023 |
| المجموعة: | PubMed Central (PMC) |
| مصطلحات موضوعية: | Capecitabine, Gastric cancer, Older patients, Oxaliplatin |
| الوصف: | Capecitabine plus oxaliplatin (CapeOX) is a standard treatment option for advanced gastric cancer (AGC). We conducted a prospective multicenter phase II study to evaluate the efficacy and safety of CapeOX as a first-line therapy for AGC in older patients. |
| نوع الوثيقة: | article in journal/newspaper report |
| اللغة: | English |
| العلاقة: | https://doi.org/10.1007/s10120-023-01423-zTest; https://pubmed.ncbi.nlm.nih.gov/37610558Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640487Test/ |
| DOI: | 10.1007/s10120-023-01423-z |
| الإتاحة: | https://doi.org/10.1007/s10120-023-01423-zTest https://pubmed.ncbi.nlm.nih.gov/37610558Test https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640487Test/ |
| حقوق: | © 2023. The Author(s). |
| رقم الانضمام: | edsbas.94672058 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1007/s10120-023-01423-z |
|---|